Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors

被引:58
作者
Antonysamy, Stephen S. [1 ]
Aubol, Brandon [1 ]
Blaney, Jeff [1 ]
Browner, Michelle F. [2 ]
Giannetti, Anthony M. [2 ]
Harris, Seth F. [2 ]
Hebert, Normand [1 ]
Hendle, Joerg [1 ]
Hopkins, Stephanie [1 ]
Jefferson, Elizabeth [1 ]
Kissinger, Charles [1 ]
Leveque, Vincent [2 ]
Marciano, David [1 ]
McGee, Ethel [1 ]
Najera, Isabel [2 ]
Nolan, Brian [1 ]
Tomimoto, Masaki [1 ]
Torres, Eduardo [1 ]
Wright, Tobi [1 ]
机构
[1] SGX Pharmaceut Inc, Med Chem, San Diego, CA 92121 USA
[2] Roche Palo Alto, Palo Alto, CA 94304 USA
关键词
HCV; NS5b; fragment screening; protein crystallography;
D O I
10.1016/j.bmcl.2008.03.056
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Non-nucleoside inhibitors of HCV NS5b RNA polymerase were discovered by a fragment-based lead discovery approach, beginning with crystallographic fragment screening. The NS5b binding affinity and biochemical activity of fragment hits and inhibitors was determined by surface plasmon resonance (Biacore) and an enzyme inhibition assay, respectively. Crystallographic fragment screening hits with similar to 1-10 mM binding affinity (K-D) were iteratively optimized to give leads with similar to 200 nM biochemical activity and low mu M cellular activity in a Replicon assay. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2990 / 2995
页数:6
相关论文
共 13 条
[1]   Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus [J].
Ago, H ;
Adachi, T ;
Yoshida, A ;
Yamamoto, M ;
Habuka, N ;
Yatsunami, K ;
Miyano, M .
STRUCTURE, 1999, 7 (11) :1417-1426
[2]  
Blaney J., 2006, FRAGMENT BASED APPRO, P215
[3]   Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus [J].
Bressanelli, S ;
Tomei, L ;
Roussel, A ;
Incitti, I ;
Vitale, RL ;
Mathieu, M ;
De Francesco, R ;
Rey, FA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (23) :13034-13039
[4]   Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCVNS5B polymerase and HCV subgenomic RNA replication.: Part 2:: Tertiary amides [J].
Chan, L ;
Pereira, O ;
Reddy, TJ ;
Das, SK ;
Poisson, C ;
Courchesne, M ;
Proulx, M ;
Siddiqui, A ;
Yannopoulos, CG ;
Nguyen-Ba, N ;
Roy, C ;
Nasturica, D ;
Moinet, C ;
Bethell, R ;
Hamel, M ;
L'Heureux, L ;
David, M ;
Nicolas, O ;
Courtemanche-Asselin, P ;
Brunette, S ;
Bilimoria, D ;
Bédard, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (03) :797-800
[5]   Identification of N,N-disubstituted phenylalanines as a novel class of inhibitors of hepatitis CNS5B polymerase [J].
Chan, L ;
Reddy, TJ ;
Proulx, M ;
Das, SK ;
Pereira, O ;
Wang, WY ;
Siddiqui, A ;
Yannopoulos, CG ;
Poisson, C ;
Turcotte, N ;
Drouin, A ;
Alaoui-Ismaili, MH ;
Bethell, R ;
Hamel, M ;
L'Heureux, L ;
Bilimoria, D ;
Nguyen-Ba, N .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (08) :1283-1285
[6]   Fragment-based drug discovery [J].
Erlanson, DA ;
McDowell, RS ;
O'Brien, T .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (14) :3463-3482
[7]   Control of hepatitis C: A medicinal chemistry perspective [J].
Gordon, CP ;
Keller, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (01) :1-20
[8]   A decade of fragment-based drug design: strategic advances and lessons learned [J].
Hajduk, Philip J. ;
Greer, Jonathan .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (03) :211-219
[9]   Fragment-based lead discovery using X-ray crystallography [J].
Hartshorn, MJ ;
Murray, CW ;
Cleasby, A ;
Frederickson, M ;
Tickle, IJ ;
Jhoti, H .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (02) :403-413
[10]   Benzimidazole derivatives bearing substituted biphenyls as hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors: Structure-activity relationship studies and identification of a potent and highly selective inhibitor JTK-109 [J].
Hirashima, Shintaro ;
Suzuki, Takayoshi ;
Ishida, Tomio ;
Noji, Satoru ;
Yata, Shinji ;
Ando, Izuru ;
Komatsu, Masakazu ;
Ikeda, Satoru ;
Hashimoto, Hiromasa .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (15) :4721-4736